Product image of Linagliptin Stada (Linagliptin) supplied by GNH India

Linagliptin Stada

Active Ingredient:
Linagliptin
Origin:
EU

Linagliptin Stada (Linagliptin)

Linagliptin, the active ingredient in Linagliptin Stada, is a dipeptidyl peptidase-4 (DPP-4) inhibitor presented as an oral tablet for oral use. It is indicated for the management of type 2 diabetes mellitus in adults.
GNH India supplies Linagliptin Stada as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Stada Arzneimittel Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linagliptin Stada belongs to the DPP-4 inhibitor class and is used to improve glycaemic control in type 2 diabetes.

  • Type 2 diabetes mellitus (monotherapy): lowers fasting and post‑prandial glucose levels.
  • Type 2 diabetes mellitus (combined with metformin): enhances overall glycaemic control when added to metformin therapy.
  • Type 2 diabetes mellitus (combined with insulin): may allow reduction of insulin dose while maintaining target glucose levels.

How It Works

  • Linagliptin selectively inhibits the dipeptidyl peptidase‑4 enzyme, preventing the breakdown of endogenous incretin hormones (GLP‑1 and GIP). Elevated incretin levels increase glucose‑dependent insulin secretion, suppress glucagon release, and improve overall glycaemic regulation without causing hypoglycaemia in the absence of food intake.

Side Effects

Common Side Effects

  • Nasopharyngitis: mild inflammation of the nasal passages and throat.
  • Headache: transient mild to moderate head pain.
  • Upper respiratory tract infection: symptoms such as cough, sore throat, or congestion.
  • Dizziness: occasional light‑headed sensation.

Serious or Rare Side Effects

  • Pancreatitis: severe abdominal pain requiring immediate medical attention.
  • Severe hypersensitivity reactions: rash, angioedema, or anaphylaxis.
  • Bullous pemphigoid: rare autoimmune skin blistering condition.

Precautions & Warnings

Linagliptin Stada should be used with consideration of the following precautions.

  • Renal impairment: assess renal function before initiating therapy.
  • Hepatic impairment: monitor liver enzymes periodically.
  • Hypersensitivity: discontinue if signs of allergic reaction appear.
  • Pregnancy and lactation: prescribe only if potential benefit outweighs risk.
  • Drug interactions: review concomitant medications for possible interactions.
  • Store at ambient temperature: keep in the original pack, protect from moisture and light.

Avoid Interactions

Linagliptin Stada may interact with several medicines.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase linagliptin exposure.
  • CYP3A4 inducers (e.g., rifampin): may reduce linagliptin efficacy.

Moderate Interactions (Monitor Closely)

  • Diuretics: monitor for enhanced hypoglycaemic effect.
  • Insulin or insulin secretagogues: dose adjustment may be required to avoid hypoglycaemia.
  • Other DPP‑4 inhibitors: concurrent use is not recommended.

Frequently Asked Questions

Linagliptin Stada is prescribed to improve blood glucose control in adults with type 2 diabetes mellitus, either as a stand‑alone therapy or in combination with other antidiabetic agents such as metformin or insulin.

Linagliptin blocks the DPP‑4 enzyme, which normally degrades the incretin hormones GLP‑1 and GIP. By preserving these hormones, the drug enhances glucose‑dependent insulin release, reduces glucagon secretion, and helps maintain normal blood sugar levels.

The specific dose of Linagliptin Stada is determined by the prescribing healthcare professional based on the patient’s clinical condition, renal and hepatic function, and any concomitant medications.

Safety data for linagliptin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified prescriber.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linagliptin shares the same class mechanism as other DPP‑4 inhibitors but has a distinct pharmacokinetic profile, allowing once‑daily dosing without dose adjustment in mild to moderate renal impairment, which can be an advantage over some alternatives.

Linagliptin Stada should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain stability.

The medication is taken orally, usually once daily, with or without food, as directed by the prescribing clinician. Swallow the tablet whole with a glass of water.

Serious adverse reactions, though rare, include pancreatitis, severe hypersensitivity (including anaphylaxis), and bullous pemphigoid. Patients should seek immediate medical attention if they experience persistent abdominal pain, rash, or signs of an allergic reaction.

Linagliptin Stada is contraindicated in individuals with a known hypersensitivity to linagliptin or any component of the formulation. Caution is also advised for patients with a history of pancreatitis or severe hepatic disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.